Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis
Interferon-beta (IFN-beta) is an effective treatment for a subgroup of patients with multiple sclerosis (MS). The mechanism of action as well as the pathophysiological basis of responsiveness to IFN-beta is not well understood. To improve treatment considerations in MS patients predictive markers fo...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Clinical immunology (Orlando, Fla.). - 1999. - 128(2008), 3 vom: 01. Sept., Seite 306-13
|
|---|
| 1. Verfasser: |
Wiesemann, Elke
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Deb, Milani,
Hemmer, Bernhard,
Radeke, Heinfried H,
Windhagen, Anja |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2008
|
|---|
| Zugriff auf das übergeordnete Werk: | Clinical immunology (Orlando, Fla.)
|
|---|
| Schlagworte: | Journal Article
Research Support, Non-U.S. Gov't
Antigens, CD
B7-2 Antigen
CD40 Antigens
Cytokines
Intercellular Signaling Peptides and Proteins
PDCD1LG2 protein, human
Programmed Cell Death 1 Ligand 2 Protein
Interleukin-10
mehr...
130068-27-8
Interferon-beta
77238-31-4 |
|---|